Evaluation of Drug Affordability in Khartoum State, Sudan
|Salah Mohamed Elhassan1,2, Gamal Osman Elhassan1,3,4*, Abubakr A Alfadl3, Sara Anas Sirelkhatim4 and Khalid Omer Alfarouk5|
|1Sudan National Medical Specialization Board, Khartoum, Sudan|
|2National Medicines and Poisons Board, Ministry of Health, Khartoum, Sudan|
|3Unaizah Pharmacy College (UCP), Qassim University, Alqassim, Kingdom of Saudi Arabia|
|4Department of Pharmacy, Omdruman Islamic University, Omdruman, Khartoum, Sudan|
|5Department of Pharmacy, Alneilain University, Khartoum, Sudan|
|Corresponding Author :||Gamal Osman Elhassan
Unaizah College of Pharmacy, Qassim University
Unaizah-Alqassim, Kingdom of Saudi Arabia
E-mail: [email protected], [email protected]
|Received: January 09, 2016; Accepted: January 19, 2016; Published: January 24, 2016|
|Citation: Elhassan SM, Elhassan GO, Alfadl AA, Sirelkhatim SA, Alfarouk KO (2016) Evaluation of Drug Affordability in Khartoum State, Sudan. J Pharmacovigilance 4:191. doi:10.4172/2329-6887.1000191|
|Copyright: © 2016 Elhassan SM et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|Related article at Pubmed, Scholar Google|
Introduction: Medicine prices are often high and unaffordable not only for the majority of people in low- and middleincome countries, but also for significant number of the population without social protection or insurance in high income countries. As a result, the lack of access to essential medicines due to unaffordability in developing countries is one of the most pressing global health problems.
Objective: To provide comparable, evidence-based information for policy makers. Method: A cross sectional descriptive survey study was applied.
Results and discussion: It seems that despite of the affordability was shown for many studied conditions, but still affordability of medicines remains a major problem for Sudan.
Conclusion: It could be concluded that absence of standard treatment guidelines that are of sound scientific bases and cost-effectiveness resulting in low quality prescribing and dispensing practices which had led to wide variations in the prescribing patterns for the assessed acute and chronic conditions.